These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 9730659)
21. Riboregulators in kidney development and function. Karolina DS; Wintour EM; Bertram J; Jeyaseelan K Biochimie; 2010 Mar; 92(3):217-25. PubMed ID: 20045037 [TBL] [Abstract][Full Text] [Related]
22. Antisense oligodesoxynucleotide strategies in renal and cardiovascular disease. Haller H; Maasch C; Dragun D; Wellner M; von Janta-Lipinski M; Luft FC Kidney Int; 1998 Jun; 53(6):1550-8. PubMed ID: 9607185 [TBL] [Abstract][Full Text] [Related]
23. [Brief introduction to gene transfer technique applied in the study of kidney diseases]. Guo MY Zhonghua Bing Li Xue Za Zhi; 2003 Dec; 32(6):500-2. PubMed ID: 15038347 [No Abstract] [Full Text] [Related]
24. Modulation of renal glomerular disease using remote delivery of adenoviral-encoded solubletype II TGF-beta receptor fusion molecule. Haviv YS; Takayama K; Nagi PA; Tousson A; Cook W; Wang M; Lam JT; Naito S; Lei X; Carey DE; Curiel DT J Gene Med; 2003 Oct; 5(10):839-851. PubMed ID: 14533192 [TBL] [Abstract][Full Text] [Related]
25. Application of decoy oligodeoxynucleotides-based approach to renal diseases. Tomita N; Azuma H; Kaneda Y; Ogihara T; Morishita R Curr Drug Targets; 2004 Nov; 5(8):717-33. PubMed ID: 15578952 [TBL] [Abstract][Full Text] [Related]
26. Transfer of genetically engineered cells to the glomerulus. Kitamura M Exp Nephrol; 1999; 7(3):259-66. PubMed ID: 10352367 [TBL] [Abstract][Full Text] [Related]
28. The nephrologist of tomorrow: towards a kidney-omic future. Hanna MH; Dalla Gassa A; Mayer G; Zaza G; Brophy PD; Gesualdo L; Pesce F Pediatr Nephrol; 2017 Mar; 32(3):393-404. PubMed ID: 26961492 [TBL] [Abstract][Full Text] [Related]
29. Applications of gene therapy to kidney disease. Hanss B; Bruggeman LA Curr Opin Nephrol Hypertens; 2003 Jul; 12(4):439-45. PubMed ID: 12815341 [TBL] [Abstract][Full Text] [Related]
30. Gene therapy approach in renal disease in the 21st century. Imai E Nephrol Dial Transplant; 2001; 16 Suppl 5():26-34. PubMed ID: 11509681 [TBL] [Abstract][Full Text] [Related]
31. Gene therapy for renal disorders: what are the benefits for the elderly? Lien YH; Lai LW Drugs Aging; 2002; 19(8):553-60. PubMed ID: 12207549 [TBL] [Abstract][Full Text] [Related]
32. Development of gene therapies for cardiovascular and renal diseases by nucleic acid medicines. Fukuda N Med Chem; 2006 Jan; 2(1):13-9. PubMed ID: 16787351 [TBL] [Abstract][Full Text] [Related]
35. Mouse models to study kidney development, function and disease. Ly JP; Onay T; Quaggin SE Curr Opin Nephrol Hypertens; 2011 Jul; 20(4):382-90. PubMed ID: 21610495 [TBL] [Abstract][Full Text] [Related]
36. Perspectives for gene therapy in renal diseases. Imai E; Isaka Y Intern Med; 2004 Feb; 43(2):85-96. PubMed ID: 15005248 [TBL] [Abstract][Full Text] [Related]
37. In vivo and ex vivo analysis of tubule function. Stockand JD; Vallon V; Ortiz P Compr Physiol; 2012 Oct; 2(4):2495-525. PubMed ID: 23720256 [TBL] [Abstract][Full Text] [Related]
38. Adrenomedullin gene delivery attenuates hypertension, cardiac remodeling, and renal injury in deoxycorticosterone acetate-salt hypertensive rats. Dobrzynski E; Wang C; Chao J; Chao L Hypertension; 2000 Dec; 36(6):995-1001. PubMed ID: 11116114 [TBL] [Abstract][Full Text] [Related]